N-仲丁基-3-甲基-4-硝基-n-丙基苯胺 | 821777-12-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-仲丁基-3-甲基-4-硝基-n-丙基苯胺
• 英文名称: N-(sec-butyl)-3-methyl-4-nitro-N-propylaniline
• 英文别名: Benzenamine, 3-methyl-N-(1-methylpropyl)-4-nitro-N-propyl-；N-butan-2-yl-3-methyl-4-nitro-N-propylaniline
• CAS: 821777-12-2
• 化学式: C₁₄H₂₂N₂O₂
• 分子量: 250.341
• InChiKey: UBOXXOQPYRSORJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  49.1
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• Chemical compounds
  申请人：Blanc E. Jean-Baptiste

  公开号：US20060148893A1

  公开（公告）日：2006-07-06

  This invention relates to non-steroidal compounds that are or are believed to be modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds.

  本发明涉及非类固醇化合物，其是或被认为是雄激素、糖皮质激素、矿物质皮质激素和孕激素受体的调节剂，以及制备和使用此类化合物的方法。
• PHARMACEUTICAL COMPOSITION FOR INHIBITING THE ACCUMULATION OF AMYLOID- B PROTEIN
  申请人：Sumitomo Chemical Company, Limited

  公开号：EP2210603A1

  公开（公告）日：2010-07-28

  The present invention provides: a pharmaceutical composition for inhibiting amyloid-β protein accumulation comprising a compound of the formula (I) or a pharmaceutically acceptable salt thereof; a method for inhibiting amyloid-β protein accumulation, comprising a step of administering an effective amount of the compound of the formula (I) or a pharmaceutically acceptable salt thereof to a mammal which may be diagnosed with an amyloid-β protein-related disease; and so on.

  本发明提供：一种抑制淀粉样蛋白-β蛋白积累的药物组合物，包含式（I）化合物或其药学上可接受的盐；一种抑制淀粉样蛋白-β蛋白积累的方法，包括向可能被诊断患有淀粉样蛋白-β蛋白相关疾病的哺乳动物施用有效量的式（I）化合物或其药学上可接受的盐的步骤；等等。
• ANILINE DERIVATIVED ANDROGEN-, GLUCOCORTICOID-, MINERALCORTICOID- AND PROGESTERONE- RECEPTOR MODULATORS
  申请人：SMITHKLINE BEECHAM CORPORATION

  公开号：EP1654221A2

  公开（公告）日：2006-05-10
• PHARMACEUTICAL COMPOSITION FOR INHIBITING AMYLOID-BETA PROTEIN ACCUMULATION
  申请人：Motonaga Kozo

  公开号：US20100222434A1

  公开（公告）日：2010-09-02

  The present invention provides: a pharmaceutical composition for inhibiting amyloid-β protein accumulation comprising a compound of the formula (I) or a pharmaceutically acceptable salt thereof; a method for inhibiting amyloid-β protein accumulation, comprising a step of administering an effective amount of the compound of the formula (I) or a pharmaceutically acceptable salt thereof to a mammal which may be diagnosed with an amyloid-β protein-related disease; and so on.
• [EN] ANILINE DERIVATIVED ANDROGEN-, GLUCOCORTICOID-, MINERALCORTICOID- AND PROGESTERONE- RECEPTOR MODULATORS<br/>[FR] COMPOSES CHIMIQUES
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2005000795A2

  公开（公告）日：2005-01-06

  This invention relates to aniline derived non-steroidal compounds that are or are believed to be modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds.